Doceree, a Healthtech SaaS startup, raised $35 million in a Series B funding round led by Creageis. Eight Roads Ventures and F-Prime Capital, both existing investors, also participated. The startup announced plans to use the new funds to accelerate product development, improve technologies, expand globally, and expand its team.

Harshit Jain and Daleep Manhas founded Doceree in 2018, aiming to simplify marketing for pharmaceutical and medical device companies. The startup offers a platform that enables healthcare professionals (HCPs) to engage in programmatic messaging using proprietary data tools. This platform facilitates communication between life sciences brands and HCPs by leveraging a global network of digital endemic and point-of-care platforms, enabling the scalable delivery of personalized communications to HCPs.

Having initially launched its solutions in the US, India, and European markets, Doceree has now expanded its operations to encompass Africa, Southeast Asia, and the Gulf Cooperation Council (GCC).

The startup announced that it will launch a series of smart and connected solutions from Doceree's product portfolio in the coming months. According to the startup, these products will revolutionize the global ecosystem.

Previously, in April of the previous year, the startup received $11 million in Series A funding from Eight Roads Ventures. The round was also joined by F-Prime Capital and Alkemi Growth Capital.

“Given we are a technology-driven platform, we will further invest on artificial intelligence and machine learning technologies to make the product even more intelligent,” Jain said.

Doceree has created a proprietary technology platform called ESPYIAN for identity resolution, enabling the establishment of a database of verified and authentic medical and healthcare professionals.

Last week, Creagis, the leader of Doceree's recent funding round, announced the successful closure of its inaugural $425 million (INR 3,529 crore) fund for investments in domestic startups.